CausalSentinel

Protein Dossier — CCL11 (Eotaxin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Percent emphysema -0.158 0.093 0.0892 Wald ratio 1 trans NA
Primary sclerosing cholangitis 0.238 0.153 0.12 Wald ratio 1 trans NA
Hirschsprung’s disease -1.66 1.14 0.147 Wald ratio 1 trans NA
Gallbladder cancer 1.37 1.61 0.392 Wald ratio 1 trans NA

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5301_7_3 Eotaxin Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

29 association rows across 18 traits (26 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
CCL13/CCL8 protein level ratio 9e-495 rs11652256 1 GCST90313676 no MR -> candidate analysis
CCL13 protein levels 7e-95 rs1233650 1 GCST90468565 no MR -> candidate analysis
CCL8 protein levels 1e-66 rs184953165 7 GCST90468586 no MR -> candidate analysis
Circulating CCL11 levels (id: OID00505_OID20668) 3e-61 rs79722574 2 GCST90859861 no MR -> candidate analysis
Circulating CCL11 levels (id: OID00970_OID20668) 5e-47 rs79722574 2 GCST90860201 no MR -> candidate analysis
Circulating CCL7 levels (id: OID00474_OID20523) 2e-42 rs3091323 1 GCST90859834 no MR -> candidate analysis
Circulating CCL7 levels (id: OID00755_OID20523) 4e-32 rs3091323 1 GCST90860091 no MR -> candidate analysis
Blood protein levels 2e-30 rs2215184 1 GCST010104 no MR -> candidate analysis
C-C motif chemokine 7 levels 3e-24 rs16969454 1 GCST90162169 no MR -> candidate analysis
CCL7 protein levels 2e-22 rs1233653 2 GCST90428425 no MR -> candidate analysis
Circulating CCL13 levels (id: OID00504_OID20655) 2e-21 rs202247332 1 GCST90859860 no MR -> candidate analysis
Circulating CCL13 levels (id: OID00768_OID20655) 2e-17 rs202247332 1 GCST90860103 no MR -> candidate analysis
…and 6 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 821 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
inflammatory bowel disease 0.471 common-variant locus no MR -> candidate analysis
vertebral column disorder 0.375 common-variant locus no MR -> candidate analysis
psoriasis 0.26 common-variant locus no MR -> candidate analysis
hyperpituitarism 0.244 common-variant locus no MR -> candidate analysis
ulcerative colitis 0.089 common-variant locus no MR -> candidate analysis
Apnea 0.137 common-variant locus no MR -> candidate analysis
Crohn disease 0.111 common-variant locus no MR -> candidate analysis
colitis 0.053 common-variant locus no MR -> candidate analysis
drug allergy 0.117 common-variant locus no MR -> candidate analysis

Of the 9 rows above, 9 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (Eotaxin)
gnomAD constraint pLI=0.0027, LOEUF=1.81 — LoF-tolerant
GWAS Catalog 104 unique SNPs / 212 rows
ClinVar 41 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance